by Sue Robbins | Aug 12, 2019 | Migraine
An intravenous formulation of a calcitonin gene–related peptide inhibitor monoclonal antibody showed efficacy for preventing chronic migraine headaches for 3 months in a dose-ranging, phase 3 trial with 1,072 patients. Read more...
by Sue Robbins | Aug 8, 2019 | Migraine
SEE GRAPH – Association between servings of caffeinated beverages compared to none and occurrence of migraine on the same day among 98 participants with episodic migraines followed for 6 weeks. Read more...
by Sue Robbins | Aug 7, 2019 | Migraine
Lenses that transition in sunlight to become sunglasses help protect eyes from dust, bugs, drying breezes and, most important of all, the damaging effects of ultraviolet light. Read more here.
by Sue Robbins | Aug 6, 2019 | Migraine
Higher perceived stress was associated with higher migraine frequency, but not chronic migraine, a new study found. Read more here.
by Sue Robbins | Aug 4, 2019 | Migraine
The more exposure that a person without migraine has to people with the disorder, the more likely he or she is to have potentially stigmatizing attitudes toward migraine, according to an analysis presented at the annual meeting of the American Headache Society. Read...
by Dr Robbins | Jul 30, 2019 | Migraine
The article by Depre and colleagues demonstrated that the new migraine preventive erenumab may be safe for stable angina...
